Answers are grounded in this paper and cite their sources.
A clinical trial was conducted to compare intramuscular (im) with subcutaneous (sc) routes for administration of quadrivalent meningococcal polysaccharide vaccine in 141 adults. Safety assessment showed the im route had reduced erythema (P<.01) and reduced headache on days 1 and 2 (P<.05). Serological testing for serum bactericidal antibody titers against capsular groups A and C did not detect significant differences.
No takes yet. Share an insight, caveat, or question.
Ruben et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: